Glucose transporters in diabetic nephropathy

Area of Science:

• Nephrology
• Diabetology
• Molecular Biology

Background:

• Diabetic nephropathy (DN) is a major complication of diabetes mellitus.
• Early changes in glomerular cells, including glucose transporter expression, contribute to DN pathogenesis.
• Glomerular cells, particularly mesangial cells, show altered glucose transporter expression in diabetes.

Purpose of the Study:

• To investigate the role of glucose transporter 1 (GLUT1) in the development of diabetic nephropathy.
• To explore the pathogenic mechanisms linking GLUT1 overexpression to extracellular matrix (ECM) expansion in DN.
• To examine the potential influence of GLUT1 gene polymorphisms on DN predisposition.

Main Methods:

• Analysis of glucose transporter expression in glomerular cells from diabetic models.
• Investigation of the signaling pathways activated by GLUT1 overexpression, including the polyol pathway and protein kinase C (PKC) isoforms.
• Assessment of the impact of GLUT1 on fibronectin expression and ECM accumulation.
• Exploration of GLUT1 gene polymorphisms in diabetic patients.

Main Results:

• GLUT1 overexpression in mesangial cells is an early event in diabetes and contributes to ECM expansion.
• GLUT1 upregulation increases glucose metabolic flux, activating the polyol pathway and PKC alpha and B1.
• PKC activation leads to AP-1-induced fibronectin expression and ECM accumulation.
• Novel roles for GLUT1 in cellular hypertrophy and injury may also promote DN.

Conclusions:

• GLUT1 plays a significant pathogenic role in diabetic nephropathy development.
• Strategies aimed at preventing GLUT1 overexpression could be effective in managing or preventing DN progression.
• Genetic predisposition to DN may be linked to GLUT1 gene polymorphisms.